{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:29:50Z","timestamp":1790141390243,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:00:00Z","timestamp":1631923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:00:00Z","timestamp":1631923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000925","name":"national health and medical research council","doi-asserted-by":"crossref","award":["251638"],"award-info":[{"award-number":["251638"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"national health and medical research council","doi-asserted-by":"crossref","award":["299831"],"award-info":[{"award-number":["299831"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"national health and medical research council","doi-asserted-by":"crossref","award":["628582"],"award-info":[{"award-number":["628582"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001778","name":"Deakin University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001778","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s11657-021-01004-6","type":"journal-article","created":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T08:02:51Z","timestamp":1631952171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association between bone measures and use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5064-2990","authenticated-orcid":false,"given":"Kara L.","family":"Holloway-Kew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia G.","family":"Betson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara B.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Gaston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Kotowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Hui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Henneberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Pasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,18]]},"reference":[{"key":"1004_CR1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s12020-014-0167-4","volume":"46","author":"M Ghosh","year":"2014","unstructured":"Ghosh M, Majumdar SR (2014) Antihypertensive medications, bone mineral density, and fractures: a review of old cardiac drugs that provides new insights into osteoporosis. Endocrine 46:397\u2013405. https:\/\/doi.org\/10.1007\/s12020-014-0167-4","journal-title":"Endocrine"},{"key":"1004_CR2","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12018-015-9182-0","volume":"13","author":"LS Bislev","year":"2015","unstructured":"Bislev LS, Sikj\u00e6r T, Rolighed L, Rejnmark L (2015) Relationship between aldosterone and parathyroid hormone, and the effect of angiotensin and aldosterone inhibition on bone health. Clin Rev Bone Miner Metab 13:194\u2013205. https:\/\/doi.org\/10.1007\/s12018-015-9182-0","journal-title":"Clin Rev Bone Miner Metab"},{"key":"1004_CR3","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.amjcard.2007.05.011","volume":"100","author":"T Unger","year":"2007","unstructured":"Unger T, Stoppelhaar M (2007) Rationale for double renin-angiotensin-aldosterone system blockade. Am J Cardiol 100:S25\u2013S31. https:\/\/doi.org\/10.1016\/j.amjcard.2007.05.011","journal-title":"Am J Cardiol"},{"key":"1004_CR4","unstructured":"National Heart Foundation of Australia (2016) Guideline for the diagnosis and management of hypertension in adults - 2016. Melbourne: National Heart Foundation of Australia"},{"key":"1004_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12018-015-9189-6","volume":"13","author":"J Tamargo","year":"2015","unstructured":"Tamargo J, Caballero R, Delp\u00f3n E (2015) The renin\u2013angiotensin system and bone. Clin Rev Bone Miner Metab 13:125\u2013148. https:\/\/doi.org\/10.1007\/s12018-015-9189-6","journal-title":"Clin Rev Bone Miner Metab"},{"key":"1004_CR6","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1007\/s00198-011-1831-7","volume":"23","author":"T Kwok","year":"2012","unstructured":"Kwok T, Leung J, Zhang YF et al (2012) Does the use of ACE inhibitors or angiotensin receptor blockers affect bone loss in older men? Osteoporos Int 23:2159\u20132167. https:\/\/doi.org\/10.1007\/s00198-011-1831-7","journal-title":"Osteoporos Int"},{"key":"1004_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/01.mnh.0000133975.32559.6b","volume":"13","author":"NS Krieger","year":"2004","unstructured":"Krieger NS, Frick KK, Bushinsky DA (2004) Mechanism of acid-induced bone resorption. Curr Opin Nephrol Hypertens 13:423\u2013436","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1004_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1359\/jbmr.081006","volume":"24","author":"Y Asaba","year":"2009","unstructured":"Asaba Y, Ito M, Fumoto T et al (2009) Activation of renin-angiotensin system induces osteoporosis independently of hypertension. J Bone Miner Res 24:241\u2013250. https:\/\/doi.org\/10.1359\/jbmr.081006","journal-title":"J Bone Miner Res"},{"key":"1004_CR9","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/hr.2009.99","volume":"32","author":"H Shimizu","year":"2009","unstructured":"Shimizu H, Nakagami H, Osako MK et al (2009) Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats. Hypertens Res 32:786\u2013790. https:\/\/doi.org\/10.1038\/hr.2009.99","journal-title":"Hypertens Res"},{"key":"1004_CR10","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3346\/jkms.2013.28.8.1139","volume":"28","author":"KY Kang","year":"2013","unstructured":"Kang KY, Kang Y, Kim M et al (2013) The effects of antihypertensive drugs on bone mineral density in ovariectomized mice. J Korean Med Sci 28:1139\u20131144. https:\/\/doi.org\/10.3346\/jkms.2013.28.8.1139","journal-title":"J Korean Med Sci"},{"key":"1004_CR11","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S1734-1140(12)70882-4","volume":"64","author":"BO Donmez","year":"2012","unstructured":"Donmez BO, Ozdemir S, Sarikanat M et al (2012) Effect of angiotensin II type 1 receptor blocker on osteoporotic rat femurs. Pharmacol Reports 64:878\u2013888. https:\/\/doi.org\/10.1016\/S1734-1140(12)70882-4","journal-title":"Pharmacol Reports"},{"key":"1004_CR12","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bone.2005.09.011","volume":"38","author":"H Lynn","year":"2006","unstructured":"Lynn H, Kwok T, Wong SYS et al (2006) Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. Bone 38:584\u2013588. https:\/\/doi.org\/10.1016\/j.bone.2005.09.011","journal-title":"Bone"},{"key":"1004_CR13","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s00774-012-0363-3","volume":"30","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Qin L, Leung P, Kwok TCY (2012) The effect of angiotensin-converting enzyme inhibitor use on bone loss in elderly Chinese. J Bone Miner Metab 30:666\u2013673. https:\/\/doi.org\/10.1007\/s00774-012-0363-3","journal-title":"J Bone Miner Metab"},{"key":"1004_CR14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11657-017-0387-3","volume":"12","author":"N Rianon","year":"2017","unstructured":"Rianon N, Ambrose CG, Pervin H et al (2017) Long-term use of angiotensin-converting enzyme inhibitors protects against bone loss in African-American elderly men. Arch Osteoporos 12:94. https:\/\/doi.org\/10.1007\/s11657-017-0387-3","journal-title":"Arch Osteoporos"},{"key":"1004_CR15","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1093\/ije\/dyr148","volume":"41","author":"JA Pasco","year":"2012","unstructured":"Pasco JA, Nicholson GC, Kotowicz MA (2012) Cohort Profile: Geelong Osteoporosis Study. Int J Epidemiol 41:1565\u20131575","journal-title":"Int J Epidemiol"},{"key":"1004_CR16","unstructured":"Adverse Drug Reactions Advisory Committee (1999) Australian Adverse Drug Reactions Bulletin. 18:1\u20134"},{"key":"1004_CR17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/med.0000000000000365","volume":"24","author":"P Martineau","year":"2017","unstructured":"Martineau P, Silva BC, Leslie WD (2017) Utility of trabecular bone score in the evaluation of osteoporosis. Curr Opin Endocrinol Diabetes Obes 24:402\u2013410. https:\/\/doi.org\/10.1097\/med.0000000000000365","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1004_CR18","unstructured":"Giles GG, Ireland PD (1996) Dietary Questionnaire for Epidemiological Studies (Version 2), Melbourne. Cancer Counc Victoria"},{"key":"1004_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383","journal-title":"J Chronic Dis"},{"key":"1004_CR20","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00198-009-1042-7","volume":"21","author":"MJ Henry","year":"2010","unstructured":"Henry MJ, Pasco JA, Korn S et al (2010) Bone mineral density reference ranges for Australian men: Geelong Osteoporosis Study. Osteoporos Int 21:909\u2013917","journal-title":"Osteoporos Int"},{"key":"1004_CR21","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1440-1673.2004.01351.x","volume":"48","author":"MJ Henry","year":"2004","unstructured":"Henry MJ, Pasco JA, Pocock NA et al (2004) Reference ranges for bone densitometers adopted Australia-wide: Geelong osteoporosis study. Australas Radiol 48:473\u2013475","journal-title":"Australas Radiol"},{"key":"1004_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10133","volume":"3","author":"KB Anderson","year":"2019","unstructured":"Anderson KB, Holloway-Kew KL, Hans D et al (2019) Reference ranges for trabecular bone score in Australian men and women: a cross-sectional study. JBMR Plus 3:e10133. https:\/\/doi.org\/10.1002\/jbm4.10133","journal-title":"JBMR Plus"},{"key":"1004_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijcard.2015.01.072","volume":"184","author":"HJ Choi","year":"2015","unstructured":"Choi HJ, Park C, Lee Y-K et al (2015) Risk of fractures in subjects with antihypertensive medications: a nationwide claim study. Int J Cardiol 184:62\u201367. https:\/\/doi.org\/10.1016\/j.ijcard.2015.01.072","journal-title":"Int J Cardiol"},{"key":"1004_CR24","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/jbmr.356","volume":"26","author":"DH Solomon","year":"2011","unstructured":"Solomon DH, Mogun H, Garneau K, Fischer MA (2011) Risk of fractures in older adults using antihypertensive medications. J Bone Miner Res 26:1561\u20131567. https:\/\/doi.org\/10.1002\/jbmr.356","journal-title":"J Bone Miner Res"},{"key":"1004_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/ageing\/afw150","volume":"46","author":"T Kwok","year":"2017","unstructured":"Kwok T, Leung J, Barrett-Connor E, Group for the OF in M (MrOS) R (2017) ARB users exhibit a lower fracture incidence than ACE inhibitor users among older hypertensive men. Age Ageing 46:57\u201364. https:\/\/doi.org\/10.1093\/ageing\/afw150","journal-title":"Age Ageing"},{"key":"1004_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/HJH.0000000000002245","volume":"38","author":"T Bokrantz","year":"2020","unstructured":"Bokrantz T, Schi\u00f6ler L, Bostr\u00f6m KB et al (2020) Antihypertensive Drug Classes and the Risk of Hip Fracture: Results From the Swedish Primary Care Cardiovascular Database. J Hypertens 38:167\u2013175","journal-title":"J Hypertens"},{"key":"1004_CR27","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1002\/jbmr.2271","volume":"29","author":"DA Butt","year":"2014","unstructured":"Butt DA, Mamdani M, Gomes T et al (2014) Risk of osteoporotic fractures with angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in hypertensive community-dwelling elderly. J Bone Miner Res 29:2483\u20132488. https:\/\/doi.org\/10.1002\/jbmr.2271","journal-title":"J Bone Miner Res"},{"key":"1004_CR28","doi-asserted-by":"crossref","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2006) Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case\u2013control study. J Hypertens 24","DOI":"10.1097\/01.hjh.0000203845.26690.cb"},{"key":"1004_CR29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ijcard.2019.12.069","volume":"305","author":"Y-T Kao","year":"2020","unstructured":"Kao Y-T, Huang C-Y, Fang Y-A, Liu J-C (2020) The association between renin angiotensin aldosterone system blockers and future osteoporotic fractures in a hypertensive population - a population-based cohort study in Taiwan. Int J Cardiol 305:147\u2013153. https:\/\/doi.org\/10.1016\/j.ijcard.2019.12.069","journal-title":"Int J Cardiol"},{"key":"1004_CR30","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1007\/s00198-019-05041-3","volume":"30","author":"LD Carbone","year":"2019","unstructured":"Carbone LD, Vasan S, Prentice RL et al (2019) The renin-angiotensin aldosterone system and osteoporosis: findings from the Women\u2019s Health Initiative. Osteoporos Int 30:2039\u20132056. https:\/\/doi.org\/10.1007\/s00198-019-05041-3","journal-title":"Osteoporos Int"},{"key":"1004_CR31","doi-asserted-by":"publisher","first-page":"e8331","DOI":"10.1097\/MD.0000000000008331","volume":"96","author":"C-I Chen","year":"2017","unstructured":"Chen C-I, Yeh J-S, Tsao N-W et al (2017) Association between renin-angiotensin-aldosterone system blockade and future osteoporotic fracture risk in hypertensive population: a population-based cohort study in Taiwan. Medicine (Baltimore) 96:e8331\u2013e8331. https:\/\/doi.org\/10.1097\/MD.0000000000008331","journal-title":"Medicine (Baltimore)"},{"key":"1004_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.14283\/jfa.2019.38","volume":"9","author":"C Shea","year":"2020","unstructured":"Shea C, Witham MD (2020) Association between the use of angiotensin-blocking medications with hip fracture and death in older people. J Frailty Aging 9:107\u2013110. https:\/\/doi.org\/10.14283\/jfa.2019.38","journal-title":"J Frailty Aging"},{"key":"1004_CR33","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s10654-017-0285-4","volume":"32","author":"SK Kunutsor","year":"2017","unstructured":"Kunutsor SK, Blom AW, Whitehouse MR et al (2017) Renin-angiotensin system inhibitors and risk of fractures: a prospective cohort study and meta-analysis of published observational cohort studies. Eur J Epidemiol 32:947\u2013959. https:\/\/doi.org\/10.1007\/s10654-017-0285-4","journal-title":"Eur J Epidemiol"},{"key":"1004_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12877-015-0154-5","volume":"15","author":"S Ruths","year":"2015","unstructured":"Ruths S, Bakken MS, Ranhoff AH et al (2015) Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study. BMC Geriatr 15:153. https:\/\/doi.org\/10.1186\/s12877-015-0154-5","journal-title":"BMC Geriatr"},{"key":"1004_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0895-7061(03)00845-8","volume":"16","author":"JL P\u00e9rez-Castrill\u00f3n","year":"2003","unstructured":"P\u00e9rez-Castrill\u00f3n JL, Silva J, Justo I et al (2003) Effect of quinapril, quinapril-hydrochlorothiazide, and enalapril on the bone mass of hypertensive subjects: relationship with angiotensin converting enzyme polymorphisms. Am J Hypertens 16:453\u2013459. https:\/\/doi.org\/10.1016\/S0895-7061(03)00845-8","journal-title":"Am J Hypertens"},{"key":"1004_CR36","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.peptides.2005.03.010","volume":"26","author":"UM Steckelings","year":"2005","unstructured":"Steckelings UM, Kaschina E, Unger T (2005) The AT2 receptor\u2014a matter of love and hate. Peptides 26:1401\u20131409. https:\/\/doi.org\/10.1016\/j.peptides.2005.03.010","journal-title":"Peptides"},{"key":"1004_CR37","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1001\/jama.296.11.1353","volume":"296","author":"JA Pasco","year":"2006","unstructured":"Pasco JA, Kotowicz MA, Henry MJ, Nicholson GC, Spilsbury HJ, Box JDSH (2006) High sensitivity C-reactive protein and fracture risk in elderly women. JAMA 296:1353\u20131355","journal-title":"JAMA"},{"key":"1004_CR38","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.bbrc.2004.11.076","volume":"328","author":"JMW Quinn","year":"2005","unstructured":"Quinn JMW, Gillespie MT (2005) Modulation of osteoclast formation. Biochem Biophys Res Commun 328:739\u2013745. https:\/\/doi.org\/10.1016\/j.bbrc.2004.11.076","journal-title":"Biochem Biophys Res Commun"},{"key":"1004_CR39","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/j.lfs.2004.04.026","volume":"75","author":"N Tanabe","year":"2004","unstructured":"Tanabe N, Ito-Kato E, Suzuki N et al (2004) IL-1\u03b1 affects mineralized nodule formation by rat osteoblasts. Life Sci 75:2317\u20132327. https:\/\/doi.org\/10.1016\/j.lfs.2004.04.026","journal-title":"Life Sci"},{"key":"1004_CR40","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99015","volume":"3","author":"W-H Liao","year":"2018","unstructured":"Liao W-H, Suendermann C, Steuer AE et al (2018) Aldosterone deficiency in mice burdens respiration and accentuates diet-induced hyperinsulinemia and obesity. JCI Insight 3:e99015. https:\/\/doi.org\/10.1172\/jci.insight.99015","journal-title":"JCI Insight"},{"key":"1004_CR41","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3389\/fphys.2016.00222","volume":"7","author":"F-L Yuan","year":"2016","unstructured":"Yuan F-L, Xu M-H, Li X et al (2016) The roles of acidosis in osteoclast biology. Front Physiol 7:222","journal-title":"Front Physiol"},{"key":"1004_CR42","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s12018-015-9191-z","volume":"13","author":"DA Butt","year":"2015","unstructured":"Butt DA, Alharty R, Leu R, Cheung AM (2015) Hypertension, antihypertensive drugs and the risk of fractures. Clin Rev Bone Miner Metab 13:160\u2013172. https:\/\/doi.org\/10.1007\/s12018-015-9191-z","journal-title":"Clin Rev Bone Miner Metab"},{"key":"1004_CR43","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s12018-015-9193-x","volume":"13","author":"JK Hwang","year":"2015","unstructured":"Hwang JK, Leu R, Butt DA (2015) Hypertension, antihypertensive drugs, and bone mineral density. Clin Rev Bone Miner Metab 13:149\u2013159. https:\/\/doi.org\/10.1007\/s12018-015-9193-x","journal-title":"Clin Rev Bone Miner Metab"},{"key":"1004_CR44","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00223-012-9671-9","volume":"92","author":"K Ili\u0107","year":"2013","unstructured":"Ili\u0107 K, Obradovi\u0107 N, Vujasinovi\u0107-Stupar N (2013) The relationship among hypertension, antihypertensive medications, and osteoporosis: a narrative review. Calcif Tissue Int 92:217\u2013227. https:\/\/doi.org\/10.1007\/s00223-012-9671-9","journal-title":"Calcif Tissue Int"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-021-01004-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-021-01004-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-021-01004-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T15:04:02Z","timestamp":1642086242000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-021-01004-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,18]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1004"],"URL":"https:\/\/doi.org\/10.1007\/s11657-021-01004-6","relation":{},"ISSN":["1862-3522","1862-3514"],"issn-type":[{"value":"1862-3522","type":"print"},{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,18]]},"assertion":[{"value":"25 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Barwon Health Human Research Ethics Committee approved the study (projects 92\/01 and 00\/56).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KLH-K is supported by an Alfred Deakin Postdoctoral Research Fellowship and KBA by an Australian Government Research Training Program Scholarship. AGB, JG, MAK, W-HL, MH, and JAP declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"137"}}